.jpg)
1 hour ago
3
Article content
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
AGOURA HILLS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) — Onoctelic Therapeutics Inc. (OTCQB:OTLC), based in Agoura Hills, focused on Oncology Drug Development, today announced that Dr. Vuong Trieu, CEO and Chairman, will present live at the OTCQB Virtual Investor Conference hosted by VirtualInvestorConferences.com, on August 6th, 2026.
Article content
Article content
Article content
DATE: August 6th
TIME: 2:30 PM ET
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Article content
Schedule 1×1 meetings here.
Article content
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
Article content
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Article content
Article content
Recent Company Highlights
Article content
- Phase 1b IV Everolimus (Sapu003) advanced to the next dose cohort following an independent Safety Review Committee recommendation.
- European clinical expansion initiated, adding new international study sites.
- Two peer-reviewed publications validated the Deciparticle™ platform and its clinical translation.
- Clinical-stage manufacturing established with scalable cGMP production of Deciparticle™ formulations.
- AI platform expanded through PDAOAI™ and pharmaceutical robotics initiatives integrating drug discovery with GMP manufacturing.
- Multiple technology platforms progressing simultaneously, including clinical oncology, AI drug discovery, robotics, and nanomedicine.
Article content
Article content
About Oncotelic Therapeutics
Article content
Oncotelic Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cancer and other serious diseases through precision medicine, RNA therapeutics, artificial intelligence, and advanced nanomedicine delivery technologies. The Company’s portfolio includes clinical-stage oncology assets, proprietary Deciparticle™ drug delivery technology, AI-enabled drug discovery platforms, and scalable GMP manufacturing capabilities designed to accelerate development while improving patient outcomes.
Article content
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Article content
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Article content
CONTACTS:
Oncotelic Therapeutics
Investor Relations
IBN (InvestorBrandNetwork)
Phone: (310) 299-1717
Email: [email protected]
Article content
Virtual Investor Conferences
Greg Young
VP Corporate Services
OTC Markets Group
(212) 652-5958
[email protected]
Article content
Article content
Article content
Article content
Article content
Article content
English (US)